Atomic layer deposition (ALD) of TiO2 thin films using Ti isopropoxide and tetrakis-dimethyl-amido titanium (TDMAT) as two kinds of Ti precursors and water as another reactant was investigated. TiO2 films with high purity can be grown in a self-limited ALD growth mode by using either Ti isopropoxide or TDMAT as Ti precursors. Different growth behaviors as a function of deposition temperature were observed. A typical growth rate curve-increased growth rate per cycle (GPC) with increasing temperatures was observed for the TiO2 film deposited by Ti isopropoxide and H2O, while surprisingly high GPC was observed at low temperatures for the TiO2 film deposited by TDMAT and H2O. An energetic model was proposed to explain the different growth behaviors with different precursors. Density functional theory (DFT) calculation was made. The GPC in the low temperature region is determined by the reaction energy barrier. From the experimental results and DFT calculation, we found that the intermediate product stability after the ligand exchange is determined by the desorption behavior, which has a huge effect on the width of the ALD process window.
Atomic layer deposition ͑ALD͒ of TiO 2 films from tetrakis͑dimethylamido͒ titanium ͑TDMAT͒ or titanium tetraisopropoxide ͑TTIP͒ precursors was investigated. The growth kinetics, chemical composition, and crystallization behavior of the TiO 2 films were compared for combinations of the two precursors with three different sources of oxygen ͓thermal ALD using H 2 O and plasma-enhanced ALD ͑PEALD͒ using H 2 O or O 2 plasma͔. For TDMAT, the growth rate per cycle ͑GPC͒ decreased with increasing temperature; while for TTIP with either water plasma or O 2 plasma, a relatively constant growth rate per cycle was observed as a function of substrate temperature. It was found that the crystallization temperature of the TiO 2 films depends both on film thickness and on the deposition conditions. A correlation was observed between the TiO 2 crystallization temperature and the C impurity concentration in the film. The TiO 2 films grown using a H 2 O plasma exhibit the lowest crystallization temperature and have no detectable C impurities. In situ X-ray diffraction measurements were used to test the diffusion barrier properties of the TiO 2 layers and proved that all TiO 2 films grown using either H 2 O or O 2 plasma are dense and continuous.
Vanadium pentoxide was deposited by atomic layer deposition (ALD) from vanadyl-tri-isopropoxide (VTIP). Water or oxygen was used as a reactive gas in thermal and plasma-enhanced (PE) processes. For PE ALD, there was a wide ALD temperature window from 50 to
200°C
. Above
200°C
, VTIP decomposed thermally, resulting in the chemical vapor deposition (CVD) of vanadium pentoxide. The PE ALD reactions saturated much faster than during thermal ALD, leading to a growth rate of approximately 0.7 Å/cycle during PE ALD using
normalH2O
or
normalO2
. Optical emission spectroscopy showed combustion-like reactions during the plasma step. X-ray diffraction was performed to determine the crystallinity of the films after deposition and after postannealing under He or
normalO2
atmosphere. Films grown with CVD at
300°C
and PE
normalO2
ALD at
150°C
were (001)-oriented
normalV2normalO5
as deposited, while thermal and PE
normalH2O
ALD films grown at
150°C
were amorphous as deposited. The crystallinity of the PE
normalO2
ALD could be correlated to its high purity, while the other films had significant carbon contamination, as shown by X-ray photoelectron spectroscopy. Annealing under He led to oxygen-deficient films, while all samples eventually crystallized into
normalV2normalO5
under
normalO2
.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.